.
BROOKS financial statements
* Numbers in millions
Year |
2020 | 2021 | TTM |
|---|---|---|---|
Capitalization * |
619 | 2 101 | 2 239 |
EV * |
891 | 2 406 | 2 406 |
Stock price ¤ |
35.15 | 85.05 | 90.65 |
Number of shares * |
18 | 25 | 25 |
EPS |
-13,84 | -7,84 | -7,84 |
Revenue * |
691 | 771 | 771 |
Net income * |
-244 | -194 | -194 |
Operating profit * |
-92 | -66 | -66 |
Total liabilities * |
594 | 829 | 829 |
Net debt * |
272 | 305 | 305 |
Total assets * |
1 579 | 1 621 | 1 621 |
Equity * |
984 | 791 | 791 |
Cash and investments * |
4 | 21 | 21 |
Over the past 10 years, the maximum capitalization of Brooks Laboratories Limited is 2 101, the minimum is 619. Maximum net income 0, Minimum net income -244. The maximum price of BROOKS shares is 85.05, the minimum price is 35.15.
.
BROOKS valuation
Year |
2020 | 2021 | TTM |
|---|---|---|---|
P/E |
-2,54 | -10,84 | -11,56 |
P/B |
0,63 | 2,65 | 2,83 |
P/S |
0,90 | 2,73 | 2,91 |
E/P |
-39% | -9% | -9% |
P/FCF |
-5,17 | -181,90 | -193,88 |
.
BROOKS profitability
Year |
2020 | 2021 | TTM |
|---|---|---|---|
ROE |
-25% | -24% | |
ROA |
-15% | -12% | |
ROIC |
-8% | -7% |